Interim Report 2022

23 舜宇光學科技（集團）有限公司 • 2022 中報 Management Discussion and Analysis 管理層討論與分析 * The English name of each of the unlisted financial products is for identification only. If there is any inconsistency, the Chinese names shall prevail. # Other unlisted financial products included 55 unlisted financial products with 8 different banks to lower the concentration risk. The fair value of such 55 unlisted financial products as at 30 June 2022 was approximately RMB107.3 million in average. In the opinion of the Directors, the fair value change of the unlisted financial products was insignificant for the six months ended 30 June 2022. Such investment activities were funded primarily by the idle self- owned funds of the Group. The Board considers that the terms of such unlisted financial products are on normal commercial terms, fair and reasonable and in the interests of the Company and shareholders of the Company (the “ Shareholders ”) as a whole. For the six months ended 30 June 2022, the Group’s investments amounted to approximately RMB1,364.3 million, which was primarily for the purchases of property, plant and equipment, acquisition of a land use right and the necessary equipment configurations for new projects. These investments enhanced the Group’s R&D and technological application capability and production efficiency, and thus expanded the sources of revenue. Future Plans for Material Investments or Capital Assets Going forward, the Group will continue to further diversify its investments among different banks to lower the concentration risk and will closely monitor the performance of investments made and future investments plan in accordance with its prudent funding and treasury policy to utilise and to increase the yield of the idle funds of the Group while maintaining a high level of liquidity and a low level of risk. Such investment activities were made and will be made on the premises that it would not adversely affect the working capital of the Group or the operation of the Group’s principal business. The Group intends to make further investments to enhance its competitiveness in the future. * 非上市金融產品的英文名稱僅作說明用途。如中 英文不一致，則以中文為準。 # 其他非上市金融產品包括八家不同銀行的 55 項 非上市金融產品，以降低集中風險。該 55 項非 上市金融產品於二零二二年六月三十日的公允值 平均約人民幣 107,300,000 元。 董事認為，截至二零二二年六月三十日止六個 月，非上市金融產品的公允值變動並不重大。 該等投資活動主要由本集團的閒置自有資金撥 付。 董事會認為，該等非上市金融產品的條款符合 正常商業條款，屬公平合理及符合本公司及本 公司股東（「 股東 」）的整體利益。 截至二零二二年六月三十日止六個月，本集 團動用約人民幣 1,364,300,000 元進行投資活 動，主要用作購置物業、機器及設備、收購土 地使用權和新項目的必要設備配置。該等投資 增強了本集團的研發及技術應用能力和生產效 率，並拓寬了收入來源。 未來作重大投資或購入資本資產的計 劃 展望未來，本集團將繼續令其於不同銀行的投 資更多元化，以降低風險集中度，並將密切監 察根據其審慎的財政政策所作投資及未來投資 計劃之表現，以動用及增加本集團閒置資金收 益，同時維持高水平流動資金及低水平風險。 該等投資活動進行及將進行的前提為其不會對 本集團營運資金或本集團主要業務營運產生不 利影響。未來，本集團擬進一步投資以加強競 爭力。